Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vitrana is a pioneering healthcare and life sciences technology company specializing in AI-powered pharmacovigilance (PV) and patient safety solutions. Founded in 2014, the company's flagship HiLIT platform serves as an end-to-end technological backbone for drug safety operations, automating high-volume tasks such as case intake, data extraction, entity mapping, and regulatory compliance reporting. Vitrana's solutions help pharmaceutical organizations and contract research organizations (CROs) reduce case processing times by over 60% and eliminate up to 75% of manual reconciliation tasks. In April 2026, Vitrana was acquired by Parexel, a leading global CRO, to integrate its advanced AI-enabled PV technology into Parexel's Patient Safety Services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vitrana.